Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 485 publications
Asciminib and inotuzumab ozogamicin: a new combination for highly refractory Ph-positive B-cell acute lymphoblastic leukemia.
Journal: Leukemia research reports
Published: October 02, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2025
Lineage Switch of Adult B-Cell Acute Lymphoblastic Leukaemia to Acute Myeloid Leukaemia Following B-Cell-Directed Therapy.
Journal: European journal of case reports in internal medicine
Published: August 11, 2025
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 29, 2025
Incorporating Immunotherapy Into Upfront Acute Lymphoblastic Leukemia Therapy.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 18, 2025
Upfront Immunotherapy Approaches in the Management of Adults with Acute Lymphoblastic Leukemia.
Journal: Cancers
Published: July 03, 2025
Efficacy and Toxicity of Inotuzumab Ozogamicin for Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients After CD19-Chimeric Antigen Receptor T-Cell Therapy.
Journal: Pediatric blood & cancer
Published: June 23, 2025
Pharmacovigilance insights into antibody-drug conjugates: a multi-database analysis of adverse events in leukemia treatment.
Journal: Expert opinion on drug safety
Published: June 16, 2025
Acute Lymphoid Leukemia: Is Transplant Indicated for Philadelphia Chromosome Positive ALL?
Journal: Advances in experimental medicine and biology
Published: June 09, 2025
Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: June 02, 2025
Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: a plain language summary.
Journal: Expert review of hematology
Published: May 21, 2025
Treatment of Older Patients With ALL.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 12, 2025
Last Updated: 10/31/2025